Effects of early plasmin digests of fibrinogen on isometric tension development in isolated rings of rat pulmonary artery.

[1]  P. Gaffney.  Tissue plasminogen activator for thrombolytic therapy: expectation versus reality. , 1992, Journal of the Royal Society of Medicine.

[2]  C. Packer,et al.  Biphasic contractile response of pulmonary artery to hypoxia. , 1991, The American journal of physiology.

[3]  W. Nichols,et al.  Fibrin(ogen) degradation product peptide 6A increases femoral artery blood flow in dogs. , 1991, Acta physiologica Scandinavica.

[4]  H. Niwano,et al.  Fibrinolysis and Fibrinogenolysis in Disseminated Intravascular Coagulation , 1990, Thrombosis and Haemostasis.

[5]  H. Gold,et al.  Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosis. , 1986, The American journal of cardiology.

[6]  A. Malik,et al.  Pulmonary vascular effects of a fibrin(ogen)-derived vasoactive peptide. , 1986, Thrombosis research.

[7]  J. Mehta,et al.  Peptide 6A, a fibrin(ogen) degradation product, increases coronary blood flow. , 1985, The American journal of physiology.

[8]  J. Mehta,et al.  Fibrin(ogen)-derived peptide B beta 30-43 increases coronary blood flow in the anesthetized dog. , 1985, Thrombosis research.

[9]  T. Saldeen.  VASOACTIVE PEPTIDES DERIVED FROM DEGRADATION OF FIBRINOGEN AND FIBRIN , 1983, Annals of the New York Academy of Sciences.

[10]  T. Saldeen,et al.  A fibrin(ogen) derived pentapeptide induces vasodilation, prostacyclin release and an increase in cyclic AMP. , 1983, Thrombosis research.

[11]  A. Bloom.  Haemostasis and thrombosis , 1981 .

[12]  T. Petty,et al.  Elevated fibrin(ogen) degradation products in the adult respiratory distress syndrome. , 1980, The American review of respiratory disease.

[13]  A. Luterman,et al.  The role of fibrinogen degradation products in the pathogenesis of the respiratory distress syndrome. , 1977, Surgery.

[14]  P. Gaffney,et al.  Soluble high-molecular-weight E fragments in the plasmin-induced degradation products of cross-linked human fibrin. , 1975, Clinical science and molecular medicine.

[15]  P. Gaffney,et al.  Plasma Fibrinogen and its Fragments during Streptokinase Treatment , 1974, British journal of haematology.

[16]  M. Mosesson.  The fibrinogenolytic pathway of fibrinogen catabolism , 1973 .